Medical Device Industry News

Listen to Stryker's Q1 2014 earnings call

April 23, 2014 by MassDevice staff

Officials at Stryker discuss the company's Q1 2014 earnings. The company reported profits of $70 million, or 18¢ per share, on sales of $2.31 billion for the 3 months ended March 31, for profit loss of 77% on sales growth of 5.3%.

Recall charges continue to suck up Stryker's profits

April 23, 2014 by Arezu Sarvestani

Orthopedics giant Stryker reports a 77% decline in profits in its 1st quarter, driven largely by continued charges associated with hip implant and waste management system recalls.

Recall charges take a chunk out of Stryker's bottom line in Q1

Michigan orthopedics giant Stryker (NYSE:SYK) lost a little Wall Street love today after posting 1st-quarter earnings that fell shy of analysts' expectations.

Intuitive Surgical sinks following rough Q1 report

April 23, 2014 by Arezu Sarvestani

Wall Street flees from Intuitive Surgical after the company posts disappointing 1st quarter earnings.

Intuitive Surgical sinks following dismal earnings

Intuitive Surgical (NSDQ:ISRG) dropped more than 11% today as Wall Street reacted to the surgical systems maker's disappointing 1st-quarter earnings. +3 | The top 3 medtech stories for Apr. 23, 2014

April 23, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.


Sotera aims for $54M for continuous patient monitoring

April 23, 2014 by Arezu Sarvestani

Patient monitoring systems maker Sotera Wireless is looking for another $33.2 million to close a $53.9 million fundraising round.

Sotera aims for $54M for continuous patient monitoring

California-based Sotera Wireless is looking to raise $53.9 million in an ongoing funding round, with about $20.7 million raised as of Monday, regulatory filings show.

Allergan resists $47B offer by swallowing poison pill

April 23, 2014 by Arezu Sarvestani

Aesthetics company Allergan adopts a "poison pill" shareholder plan in order to fend off an unsolicited $47 billion offer from Valeant Pharmaceuticals and activist investor Pershing Square Capital Management.

Allergan fends off hostile $47B offer by swallowing poison pill

Aesthetics products maker Allergan (NYSE:AGN) last night adopted a "poison pill" strategy designed to insulate the company from a surprise $47 billion hostile takeover.

FDA may ban behavioral shock devices

April 23, 2014 by Arezu Sarvestani

U.S. healthcare regulators will meet tomorrow to consider banning the use of electrical shocking devices used in behavior modification.

FDA to consider banning behavioral electric shocks

The FDA's neurological devices panel will meet tomorrow to decide the fate of aversive electrical stimulation, devices that generate electrical shocks used by care providers in order to deter unwanted behavior.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp